KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Liveperson (LPSN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Liveperson (LPSN) over the last 17 years, with Q3 2025 value amounting to $106.7 million.

  • Liveperson's Cash & Equivalents fell 2494.16% to $106.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.7 million, marking a year-over-year decrease of 2494.16%. This contributed to the annual value of $183.2 million for FY2024, which is 1306.8% down from last year.
  • As of Q3 2025, Liveperson's Cash & Equivalents stood at $106.7 million, which was down 2494.16% from $162.0 million recorded in Q2 2025.
  • Liveperson's 5-year Cash & Equivalents high stood at $668.2 million for Q1 2021, and its period low was $3.1 million during Q1 2023.
  • Over the past 5 years, Liveperson's median Cash & Equivalents value was $212.2 million (recorded in 2023), while the average stood at $308.5 million.
  • In the last 5 years, Liveperson's Cash & Equivalents crashed by 9936.38% in 2023 and then skyrocketed by 405490.52% in 2024.
  • Over the past 5 years, Liveperson's Cash & Equivalents (Quarter) stood at $521.8 million in 2021, then dropped by 24.92% to $391.8 million in 2022, then crashed by 46.2% to $210.8 million in 2023, then dropped by 13.07% to $183.2 million in 2024, then crashed by 41.79% to $106.7 million in 2025.
  • Its Cash & Equivalents stands at $106.7 million for Q3 2025, versus $162.0 million for Q2 2025 and $176.3 million for Q1 2025.